{"id":"https://openalex.org/W3046319422","doi":"https://doi.org/10.1080/13543784.2020.1804853","title":"Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases","display_name":"Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases","alternate_titles":[],"publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3046319422","doi":"https://doi.org/10.1080/13543784.2020.1804853","mag":"3046319422","pmid":"https://pubmed.ncbi.nlm.nih.gov/32741234"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2020.1804853","doi":"https://doi.org/10.1080/13543784.2020.1804853","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1804853","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3046319422"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1080/13543784.2020.1804853","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068228244","display_name":"Kanmin Xue","orcid":"https://orcid.org/0000-0003-0065-9131","observed_orcids":["https://orcid.org/0000-0003-0065-9131"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kanmin Xue","raw_affiliation_strings":["Wellcome Trust Clinical Research Career Development Fellow, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford & Honorary Consultant Vitreoretinal Surgeon, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome Trust Clinical Research Career Development Fellow, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford & Honorary Consultant Vitreoretinal Surgeon, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046326117","display_name":"Robert Edward MacLaren","orcid":"https://orcid.org/0000-0002-3096-4682","observed_orcids":["https://orcid.org/0000-0002-3096-4682","https://orcid.org/0009-0001-5561-1365"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert E. MacLaren","raw_affiliation_strings":["Professor of Ophthalmology, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford & Honorary Consultant Vitreoretinal Surgeon, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor of Ophthalmology, Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford & Honorary Consultant Vitreoretinal Surgeon, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046326117","https://openalex.org/A5068228244"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210147381"],"apc_list":null,"apc_paid":null,"fwci":1.7409,"has_fulltext":true,"cited_by_count":76,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86831512,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"29","issue":"10","first_page":"1163","last_page":"1170"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.020999999716877937,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9940000176429749},{"id":"https://openalex.org/keywords/inherited-retinal-disease","display_name":"inherited retinal disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.7480000257492065},{"id":"https://openalex.org/keywords/intravitreal-delivery","display_name":"intravitreal delivery","score":0.8149999976158142},{"id":"https://openalex.org/keywords/compound-heterozygosity","display_name":"compound heterozygosity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/gene-augmentation","display_name":"gene augmentation","score":0.7799999713897705},{"id":"https://openalex.org/keywords/genome-editing","display_name":"genome editing","score":0.9860000014305115},{"id":"https://openalex.org/keywords/viral-vectors","display_name":"viral vectors","score":0.5659999847412109},{"id":"https://openalex.org/keywords/deep-intronic-mutation","display_name":"deep intronic mutation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6069999933242798},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6056951880455017},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.5328448414802551},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.48692548274993896},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.45382535457611084},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.448193222284317},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.44299793243408203},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.4415217936038971},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4336875081062317},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4223896861076355},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.38162344694137573},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3625298738479614},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3237558603286743},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.25780123472213745},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000072669","descriptor_name":"Gene Editing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012164","descriptor_name":"Retinal Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012164","descriptor_name":"Retinal Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012164","descriptor_name":"Retinal Diseases","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057130","descriptor_name":"Leber Congenital Amaurosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D057130","descriptor_name":"Leber Congenital Amaurosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D057130","descriptor_name":"Leber Congenital Amaurosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/13543784.2020.1804853","doi":"https://doi.org/10.1080/13543784.2020.1804853","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1804853","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:b5c648cd-ed23-4b89-86aa-df43f544c220","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:b5c648cd-ed23-4b89-86aa-df43f544c220","pdf_url":"https://ora.ox.ac.uk/objects/uuid:b5c648cd-ed23-4b89-86aa-df43f544c220/files/rv979v361s","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Symplectic Elements","raw_type":"Journal article"},{"id":"pmid:32741234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32741234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/13543784.2020.1804853","doi":"https://doi.org/10.1080/13543784.2020.1804853","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2020.1804853","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3699123710","display_name":null,"funder_award_id":"5039/5040","funder_id":"https://openalex.org/F4320320188","funder_display_name":"Fight for Sight UK"},{"id":"https://openalex.org/G4309095376","display_name":"Gene therapies for age-related macular degeneration and uveitis","funder_award_id":"216593/Z/19/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G4957989404","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0515-10047","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G6828952867","display_name":"NIHR Senior Investigator Award","funder_award_id":"NIHR201338","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320188","display_name":"Fight for Sight UK","ror":"https://ror.org/03133qe46"},{"id":"https://openalex.org/F4320320242","display_name":"Royal College of Surgeons of Edinburgh","ror":"https://ror.org/021a7d287"},{"id":"https://openalex.org/F4320323675","display_name":"Oxford University Hospitals NHS Foundation Trust","ror":"https://ror.org/03h2bh287"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3046319422.pdf","grobid_xml":"https://content.openalex.org/works/W3046319422.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W142058135","https://openalex.org/W1533447420","https://openalex.org/W1647075334","https://openalex.org/W1975297325","https://openalex.org/W1984225507","https://openalex.org/W1995773545","https://openalex.org/W2017685224","https://openalex.org/W2056519993","https://openalex.org/W2064319275","https://openalex.org/W2065110413","https://openalex.org/W2066116230","https://openalex.org/W2069146205","https://openalex.org/W2073115409","https://openalex.org/W2076400021","https://openalex.org/W2078876833","https://openalex.org/W2088398672","https://openalex.org/W2090849645","https://openalex.org/W2091796111","https://openalex.org/W2092474773","https://openalex.org/W2100844463","https://openalex.org/W2107204625","https://openalex.org/W2107677607","https://openalex.org/W2124110971","https://openalex.org/W2130886644","https://openalex.org/W2140250064","https://openalex.org/W2147124443","https://openalex.org/W2156190275","https://openalex.org/W2157085976","https://openalex.org/W2166316982","https://openalex.org/W2168019567","https://openalex.org/W2172376325","https://openalex.org/W2184051949","https://openalex.org/W2318841795","https://openalex.org/W2336621401","https://openalex.org/W2336977304","https://openalex.org/W2338378167","https://openalex.org/W2408672879","https://openalex.org/W2520424538","https://openalex.org/W2547540394","https://openalex.org/W2560202024","https://openalex.org/W2609428916","https://openalex.org/W2736065260","https://openalex.org/W2765787105","https://openalex.org/W2771247031","https://openalex.org/W2779736613","https://openalex.org/W2793784362","https://openalex.org/W2801923716","https://openalex.org/W2806617686","https://openalex.org/W2809774355","https://openalex.org/W2810909862","https://openalex.org/W2883897094","https://openalex.org/W2888444358","https://openalex.org/W2889621468","https://openalex.org/W2893026352","https://openalex.org/W2898811160","https://openalex.org/W2903772223","https://openalex.org/W2908873329","https://openalex.org/W2910182884","https://openalex.org/W2913312238","https://openalex.org/W2929837089","https://openalex.org/W2940301838","https://openalex.org/W2995799645","https://openalex.org/W3001996117","https://openalex.org/W3006116138","https://openalex.org/W3008742929","https://openalex.org/W3009991206","https://openalex.org/W3016726513","https://openalex.org/W4237375085"],"related_works":["https://openalex.org/W4414706296","https://openalex.org/W2586648334","https://openalex.org/W2406092303","https://openalex.org/W2752102134","https://openalex.org/W2506421162","https://openalex.org/W2997791590","https://openalex.org/W2768804540","https://openalex.org/W3161068680","https://openalex.org/W90989051","https://openalex.org/W4391887151"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Antisense":[1],"oligonucleotides":[2],"(ASOs)":[3],"represent":[4],"a":[5],"class":[6],"of":[7,21,37,46,58,69,72,95,117,165,172],"drugs":[8],"which":[9,79,158],"can":[10],"be":[11,53,131],"rationally":[12],"designed":[13],"to":[14,52,114,130,169],"complement":[15,153],"the":[16,56,66,93,163,166,170],"coding":[17],"or":[18,34],"non-coding":[19],"regions":[20],"target":[22],"RNA":[23,29],"transcripts.":[24],"They":[25],"could":[26],"modulate":[27],"pre-messenger":[28],"splicing,":[30],"induce":[31],"mRNA":[32],"knockdown,":[33],"block":[35],"translation":[36],"disease-causing":[38],"genes,":[39],"thereby":[40],"slowing":[41],"disease":[42],"progression.":[43],"The":[44],"pharmacokinetics":[45],"intravitreal":[47],"delivery":[48],"may":[49],"enable":[50],"ASOs":[51,133],"effective":[54],"in":[55,92,111,123],"treatment":[57,171],"inherited":[59,76,141],"retinal":[60,77,142],"diseases.":[61,174],"AREAS":[62],"COVERED:":[63],"We":[64],"review":[65],"current":[67],"status":[68],"clinical":[70,112],"trials":[71],"ASO":[73],"therapies":[74],"for":[75,138],"diseases,":[78],"have":[80],"demonstrated":[81],"safety,":[82],"viable":[83],"durability,":[84],"and":[85,102,147,168],"early":[86],"efficacy.":[87],"Future":[88],"applications":[89],"are":[90,126],"discussed":[91],"context":[94],"alternative":[96],"genetic":[97],"approaches,":[98],"including":[99],"gene":[100,103,156],"augmentation":[101,157],"editing.":[104],"EXPERT":[105],"OPINION:":[106],".":[107],"However,":[108],"potential":[109,137],"variability":[110],"response":[113],"ASO-mediated":[115],"correction":[116],"splicing":[118],"defect":[119],"on":[120],"one":[121],"allele":[122],"patients":[124],"who":[125],"compound":[127],"heterozygotes":[128],"needs":[129],"assessed.":[132],"hold":[134],"great":[135],"therapeutic":[136],"numerous":[139],"other":[140],"diseases":[143],"with":[144],"common":[145],"deep-intronic":[146],"dominant":[148],"gain-of-function":[149],"mutations.":[150],"These":[151],"would":[152],"viral":[154],"vector-mediated":[155],"is":[159],"generally":[160],"limited":[161],"by":[162],"size":[164],"transgene":[167],"recessive":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3046319422","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-08-07T00:00:00"}
